Supervisor Database Search
Guidance for ICAT Supervisors
The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.
You can read about the ICAT supervisor selection process and eligibility criteria below:
Terms of reference/guide to supervising ICAT Fellows.
You can read the terms of reference for supervisors actively supervising ICAT Fellows below:
Supervisor Database
Full NameProfessor Alan Stitt
Wellcome-Wolfson Institute for Experimental Medicine
Queen's University Belfast
Webpage:qub.ac.uk
Email hidden; Javascript is required.
- cell and developmental biology/regenerative medicine
- neuroscience and mental health
- Other
Diabetic complications, vascular biology, angiogenesis, ophthalmology, wound-healing, stem cell therapy.
- Medicine
- Surgery
- Obstetrics and Gynaecology
- Ophthalmology
- Paediatrics
- Pathology
- Cardiology
- Cardiac Surgery
- Dermatology
- Endocrinology
- Geriatric Medicine
- Haematology
- Immunology
- Neonatology
- Nephrology
- Neurophysiology
- Oncology
- Orthopaedic surgery
- Pharmacology
- Physiology
- Respiratory Medicine
- Vascular Medicine
My research group is primarily interested in understanding the pathophysiological, biochemical, cellular and molecular basis of vascular disease; using this fundamental knowledge for therapeutic target identification and drug development. Over many years there has been a particular focus on the retinal vasculature (including diabetic retinopathy, vascular occlusions, macular degeneration and retinopathy of prematurity). Our work has provided the preclinical basis for several phase I/III clinical trials and is very translationally orientated.
In recent years we have expanded our angiogenesis, cell therapy and regenerative medicine interests to include peripheral vascular disease, cardiac ischaemia, diabetic microvascular complications and wound healing. While we conduct sophisticated laboratory-based molecular cell biology approaches using in vitro and in vivo model-systems, we also isolate stem cells from peripheral and umbilical cord blood and generate induced pluripotent stem cells from patients. Much of this work is clinically orientated and most of our projects include clinical academics as integral partners in the research.
My group provides a unique basis for an enthusiastic clinical trainee to become embedded in a multidisciplinary, internationally recognised research programme and use their specialty knowledge to conduct laboratory and/or clinic-based research of the highest quality. Within the framework of the Wellcome-HRB ICAT programme, we will be encouraging publication outputs, follow-on fellowships and clinical academic career-building opportunities.